Spots Global Cancer Trial Database for A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Official Title: A 12-month, Open-label, Interventional, Multicentre Study to Investigate the Current Criteria Driving Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Study ID: NCT02034006
Interventions
Study Description
Brief Summary: The primary objective of the study was to investigate current criteria driving re-treatment in patients affected by Choroidal Neovascularization (CNV) secondary to Pathologic Myopia (PM) and experiencing a relapse of the disease after the first administration of ranibizumab.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis Investigative Site, Ancona, AN, Italy
Novartis Investigative Site, Bari, BA, Italy
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Desenzano del Garda, BS, Italy
Novartis Investigative Site, Bolzano, BZ, Italy
Novartis Investigative Site, Cagliari, CA, Italy
Novartis Investigative Site, Catania, CT, Italy
Novartis Investigative Site, Catanzaro, CZ, Italy
Novartis Investigative Site, Firenze, FI, Italy
Novartis Investigative Site, Rapallo, GE, Italy
Novartis Investigative Site, Terracina, LT, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Palermo, PA, Italy
Novartis Investigative Site, Padova, PD, Italy
Novartis Investigative Site, Padova, PD, Italy
Novartis Investigative Site, Perugia, PG, Italy
Novartis Investigative Site, Pisa, PI, Italy
Novartis Investigative Site, Parma, PR, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Siena, SI, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Conegliano, TV, Italy
Novartis Investigative Site, Udine, UD, Italy
Novartis Investigative Site, Varese, VA, Italy
Novartis Investigative Site, Negrar, VR, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, Napoli, , Italy
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
